Pale Fire Capital SE’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-775,055
Closed -$1.81M 66
2025
Q3
$1.81M Hold
775,055
0.2% 24
2025
Q2
$977K Sell
775,055
-11,667
-1% -$11.5K 0.1% 29
2025
Q1
$718K Buy
786,722
+52,518
+7% +$68.3K 0.09% 28
2024
Q4
$1.17M Sell
734,204
-700
-0.1% -$1.41K 0.26% 18
2024
Q3
$1.44M Buy
734,904
+695,797
+1,779% +$1.42M 0.23% 23
2024
Q2
$64.1K Buy
39,107
+17,407
+80% +$55.6K 0.01% 42
2024
Q1
$112K Sell
21,700
-6,500
-23% -$40.1K 0.02% 43
2023
Q4
$162K Buy
+28,200
New +$139K 0.03% 55

Other funds holding CRBU

Pale Fire Capital SE's CRBU Position: Q4 2025 in Review

Pale Fire Capital SE sold out of Caribou Biosciences (CRBU) in Q4 2025, closing a stake of 775,055 shares — an estimated $1.81M sold.

Pale Fire Capital SE first reported a position in CRBU in Q4 2023 and held it in 8 quarters. The position peaked at $1.81M in Q3 2025. 124 funds tracked by Wall St. Rank hold CRBU as of Q4 2025.

  • Pale Fire Capital SE reported no remaining Caribou Biosciences position as of Q4 2025 after selling out during the quarter.
  • Pale Fire Capital SE sold 775,055 Caribou Biosciences shares in Q4 2025, an estimated $1.81M.
  • Pale Fire Capital SE first reported a position in Caribou Biosciences in Q4 2023 and held it in 8 quarters.
  • Pale Fire Capital SE's Caribou Biosciences position peaked at $1.81M in Q3 2025.
  • 124 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2025.

Based on Pale Fire Capital SE's 13F filing for Q4 2025, filed 13 Feb 2026.